MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY for MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act. H.R. 800/S.806, a bill to remove the prompt pay discount between the manufacturer and the distributor from the providers Medicare Part B drug reimbursement. H.R. 1416, Cancer Patient Protection Act of 2013.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
| MATT BROW | — |
| KEAGAN R LENIHAN | — |
| GEOFF WERTH | — |
Taxation/Internal Revenue Code TAX
Implementation of the new medical device tax. Proposals to repeal LIFO.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Health Issues HCR
Incentives for health information technology, Affordable Care Act implementation, and other healthcare policy issues. Proposed regulation of medical software. Food and Drug Administration Safety and Innovacation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
| MATT BROW | — |
| KEAGAN R LENIHAN | — |
| GEOFF WERTH | — |
Veterans VET
Existing Department of Veterans' Affairs Pharmaceutical Prime Vendor contract.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Pharmacy PHA
Pharmacy issues, prescription drug supply chain issues, including security of the supply chain, drug shortages, prescription drug abuse and diversion.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.